Harry Alexopoulos
National and Kapodistrian University of Athens
H-index: 34
Europe-Greece
Top articles of Harry Alexopoulos
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review | Agustí Alentorn Giulia Berzero Harry Alexopoulos John Tzartos Germán Reyes Botero | 2023/5/25 | |
Serological testing for SARS-CoV-2: advancements and future challenges | European Journal of Internal Medicine | Harry Alexopoulos Ioannis P Trougakos Meletios-Athanasios Dimopoulos Evangelos Terpos | 2023/2 |
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies | Harry Alexopoulos Ioannis P Trougakos Meletios-Athanasios Dimopoulos Evangelos Terpos | 2023/1/1 | |
Exploring neurodegeneration mechanisms and potential therapeutic strategies using drosophila melanogaster as a model organism | Journal of the Neurological Sciences | Sentiljana Gumeni Xanthippi Louka Eleni-Dimitra Papanagnou Maria Manola Zoi Evangelakou | 2023/12/1 |
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis | Ioannis P Trougakos Evangelos Terpos Harry Alexopoulos Marianna Politou Dimitrios Paraskevis | 2022/7/1 | |
COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknowns | Ioannis P Trougakos Evangelos Terpos Harry Alexopoulos Marianna Politou Dimitrios Paraskevis | 2022/10/1 | |
Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, excluding those under anti-BCMA therapy | Hemasphere | Ioannis Ntanasis-Stathopoulos Vangelis Karalis Maria Gavriatopoulou Panagiotis Malandrakis Aimilia D Sklirou | 2022/8/1 |
Risk Factors and Brain Metabolic Mechanism of Sleep Disorders in Autoimmune Encephalitis | Autoimmunity and the Brain: Paraneoplastic Neurological Injury and Beyond | John Greenlee Harry Alexopoulos Jungsu S Oh Qun Wang X Liu | 2022/6/7 |
Nonparaneoplastic Anti-GAD Limbic Encephalitis: Seizure Outcome and Long-term Neuropsychological Follow-up After Immunotherapy | Cognitive and Behavioral Neurology | Martha Spilioti Andreas Kiryttopoulos Theodora Panou Panagiotis Simos Haris Alexopoulos | 2022/9/1 |
Third dose of the BNT162b2 vaccine results in sustained high levels of neutralizing antibodies against SARS-CoV-2 at 6 months following vaccination in healthy individuals | Hemasphere | Ioannis Ntanasis-Stathopoulos Vangelis Karalis Aimilia D Sklirou Maria Gavriatopoulou Harry Alexopoulos | 2022/7/1 |
Myelin-oligodendrocyte glycoprotein antibody-associated disease (vol 20, pg 762, 2021) | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Mark A Colantonio Divine C Nwafor Shruti Jaiswal Ashish K Shrestha Mahmoud Elkhooly | 2022/12 |
P-148: Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, except for those under treatment with anti-BCMA agents | Clinical lymphoma, myeloma & leukemia | Ioannis Ntanasis-Stathopoulos Vangelis Karalis Maria Gavriatopoulou Aimilia D Sklirou Panagiotis Malandrakis | 2022/8 |
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions | Popianna Tsiortou Harry Alexopoulos Marinos C Dalakas | 2021/3 | |
Anti-SARS-CoV-2 antibodies within IVIg preparations: cross-reactivities with seasonal coronaviruses, natural autoimmunity, and therapeutic implications | Frontiers in immunology | Marinos C Dalakas Kleopatra Bitzogli Harry Alexopoulos | 2021/2/17 |
AB0697 ANTI-SARS-COV-2 ANTIBODIES AND AUTOANTIBODIES IN COVID-19 PATIENTS SURVIVED AFTER ICU ADMISSION, 6 MONTHS LATER | K Bitzogli E Magira L Chatzis E Jahaj H Alexopoulos | 2021/6/1 | |
Antiphospholipid and antinuclear antibodies in children with idiopathic epilepsy: A 2-year prospective study | Journal of Clinical Neurology (Seoul, Korea) | Achilleas Attilakos Lambros Fotis Argirios Dinopoulos Harris Alexopoulos Aikaterini Vasileiou Theofilopoulou | 2020/1 |
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19 | Annals of the Rheumatic Diseases | Panayiotis G Vlachoyiannopoulos Eleni Magira Haris Alexopoulos Edison Jahaj Katerina Theophilopoulou | 2020/12/1 |
Anti-neuronal antibodies within the IVIg preparations: importance in clinical practice | Neurotherapeutics | Maria M Dimitriadou Haris Alexopoulos Sofia Akrivou Eleni Gola Marinos C Dalakas | 2020/1/1 |
Complement in neurological disorders and emerging complement-targeted therapeutics | Marinos C Dalakas Harry Alexopoulos Peter J Spaeth | 2020/11 | |
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients | Neurology: Neuroimmunology & Neuroinflammation | Harry Alexopoulos Eleni Magira Kleopatra Bitzogli Nikolitsa Kafasi Panayiotis Vlachoyiannopoulos | 2020/9/25 |
